Compare GSK plc (GSK) vs Reddit Inc (RDDT) Price & Performance

GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.

The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.

Reddit (RDDT) trades at $193.79, down 4.65% in the last session, with a bullish technical signal from moving averages. The company shows strong fundamentals with 91.37% gross margins and 28.6% net income margin, though valuation ratios remain elevated (P/E 56.58). Recent earnings beat expectations in two of the last three quarters, with Q2 2026 results due July 30, 2026.

Outlook remains positive with analyst consensus at Buy (63%) and $236.89 price target, representing 22% upside. Key risks include high valuation multiples and competitive digital advertising pressures. Revenue growth trajectory and AI safety initiatives position RDDT for sustained expansion if execution continues.